Moses Rodriguez

37.1k total citations · 5 hit papers
489 papers, 27.0k citations indexed

About

Moses Rodriguez is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Moses Rodriguez has authored 489 papers receiving a total of 27.0k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Pathology and Forensic Medicine, 105 papers in Immunology and 91 papers in Neurology. Recurrent topics in Moses Rodriguez's work include Multiple Sclerosis Research Studies (197 papers), Neurogenesis and neuroplasticity mechanisms (84 papers) and Viral Infections and Immunology Research (72 papers). Moses Rodriguez is often cited by papers focused on Multiple Sclerosis Research Studies (197 papers), Neurogenesis and neuroplasticity mechanisms (84 papers) and Viral Infections and Immunology Research (72 papers). Moses Rodriguez collaborates with scholars based in United States, Spain and France. Moses Rodriguez's co-authors include Claudia F. Lucchinetti, Brian G. Weinshenker, John H. Noseworthy, Hans Lassmann, Joseph E. Parisi, Bernd W. Scheithauer, Larry R. Pease, Wolfgang Br�ck, Arthur E. Warrington and Julian L. Leibowitz and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Moses Rodriguez

481 papers receiving 26.3k citations

Hit Papers

Heterogeneity of multiple sclerosis lesions: Implications... 1996 2026 2006 2016 2000 2000 2016 1999 1996 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
    2000 2.5k citations Moses Rodriguez et al. profile →
  2. Multiple Sclerosis
    2000 2.4k citations Moses Rodriguez et al. profile →
  3. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
    2016 700 citations Moses Rodriguez et al. profile →
  4. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
    1999 601 citations Moses Rodriguez et al. profile →
  5. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
    1996 590 citations Moses Rodriguez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moses Rodriguez United States 79 13.7k 6.5k 6.1k 5.4k 3.6k 489 27.0k
Tomas Olsson Sweden 92 14.4k 1.1× 10.6k 1.6× 5.5k 0.9× 5.8k 1.1× 3.8k 1.0× 679 31.2k
Reinhard Hohlfeld Germany 82 10.0k 0.7× 7.6k 1.2× 6.0k 1.0× 5.6k 1.0× 2.9k 0.8× 301 23.0k
Richard A. Rudick United States 71 16.0k 1.2× 2.9k 0.4× 5.5k 0.9× 3.2k 0.6× 2.7k 0.7× 214 21.7k
Ralf Gold Germany 78 10.4k 0.8× 7.1k 1.1× 8.1k 1.3× 6.3k 1.2× 3.9k 1.1× 780 28.2k
Wolfgang Brück Germany 89 14.7k 1.1× 7.1k 1.1× 6.8k 1.1× 7.7k 1.4× 8.4k 2.3× 391 32.1k
Jack P. Antel Canada 102 12.9k 0.9× 12.0k 1.8× 6.0k 1.0× 11.1k 2.1× 10.9k 3.0× 525 38.0k
Amit Bar‐Or Canada 83 14.5k 1.1× 9.1k 1.4× 5.8k 0.9× 5.0k 0.9× 4.0k 1.1× 453 25.9k
Cedric S. Raine United States 88 9.2k 0.7× 12.3k 1.9× 3.3k 0.5× 8.5k 1.6× 7.1k 2.0× 413 31.5k
W. I. McDonald United Kingdom 81 22.2k 1.6× 3.4k 0.5× 10.0k 1.6× 4.3k 0.8× 2.2k 0.6× 250 31.8k
Hans‐Peter Hartung Germany 89 20.7k 1.5× 8.2k 1.3× 14.5k 2.4× 7.9k 1.5× 4.7k 1.3× 730 43.0k

Countries citing papers authored by Moses Rodriguez

Since Specialization
Citations

This map shows the geographic impact of Moses Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moses Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moses Rodriguez more than expected).

Fields of papers citing papers by Moses Rodriguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moses Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moses Rodriguez. The network helps show where Moses Rodriguez may publish in the future.

Co-authorship network of co-authors of Moses Rodriguez

This figure shows the co-authorship network connecting the top 25 collaborators of Moses Rodriguez. A scholar is included among the top collaborators of Moses Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moses Rodriguez. Moses Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cebrián, Ignacio, Moses Rodriguez, Nathalie Brouwers, et al.. (2025). Dendritic cell phagosomes recruit GRASP55 for export of antigen-loaded MHC molecules. Cell Reports. 44(2). 115333–115333.
2.
Greenberg, Benjamin, James D. Bowen, Enrique Álvarez, et al.. (2022). A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(2). 3090454675–3090454675. 7 indexed citations
3.
Johnson, Aaron J., et al.. (2020). Remyelination-Promoting DNA Aptamer Conjugate Myaptavin-3064 Binds to Adult Oligodendrocytes In Vitro. Pharmaceuticals. 13(11). 403–403. 8 indexed citations
4.
Smestad, John, et al.. (2019). Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy. Nucleic Acid Therapeutics. 29(3). 126–135. 13 indexed citations
5.
6.
Rahmanzadeh, Reza, et al.. (2017). Demyelination with preferential MAG loss: A complex message from MS paraffin blocks. Journal of the Neurological Sciences. 385. 126–130. 6 indexed citations
7.
Belman, Anita, Lauren Krupp, Cody S. Olsen, et al.. (2016). Demographic and Clinical Characteristics of 490 Children and Adolescents with Multiple Sclerosis (MS): US Network of Pediatric MS Centers’ Experience (S29.004). Neurology. 86(16_supplement). 1 indexed citations
8.
Anderson, George, Michaël Maes, Regina P. Markus, & Moses Rodriguez. (2015). Ebola virus: Melatonin as a readily available treatment option. Journal of Medical Virology. 87(4). 537–543. 42 indexed citations
9.
Smestad, John, Justin P. Peters, Aleksandar Đenić, et al.. (2014). Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice. Nucleic Acid Therapeutics. 25(1). 11–19. 22 indexed citations
10.
Đenić, Aleksandar, Bharath Wootla, Laurie Zoecklein, & Moses Rodriguez. (2014). Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis (P1.178). Neurology. 82(10_supplement). 1 indexed citations
11.
Chitnis, Tanuja, Charles R.G. Guttmann, Alexander Musallam, et al.. (2013). Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC Neurology. 13(1). 173–173. 5 indexed citations
12.
Rodriguez, Moses, et al.. (2011). Rasburicase in cancer-related hyperuricemia. Drugs of today. 47(8). 591–591. 3 indexed citations
13.
Chitnis, Tanuja, Lauren Krupp, E. Ann Yeh, et al.. (2011). Pediatric Multiple Sclerosis. Neurologic Clinics. 29(2). 481–505. 64 indexed citations
14.
Block, Matthew S., Yanice Mendez-Fernandez, Virginia P. Van Keulen, et al.. (2005). Inability of bm14 Mice to Respond to Theiler’s Murine Encephalomyelitis Virus Is Caused by Defective Antigen Presentation, Not Repertoire Selection. The Journal of Immunology. 174(5). 2756–2762. 4 indexed citations
15.
Zhu, Gefeng, Dallas B. Flies, Koji Tamada, et al.. (2001). Progressive Depletion of Peripheral B Lymphocytes in 4-1BB (CD137) Ligand/I-Eα-Transgenic Mice. The Journal of Immunology. 167(5). 2671–2676. 50 indexed citations
16.
Das, Pritam, Kristen M. Drescher, Annemieke Geluk, et al.. (2000). Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Human Immunology. 61(3). 279–289. 42 indexed citations
17.
Drescher, Kristen M., Paul D. Murray, Xiaoqi Lin, J A Carlino, & Moses Rodriguez. (2000). TGF-β2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis. The Journal of Immunology. 164(6). 3207–3213. 33 indexed citations
18.
Hunter, Samuel F., David J. Miller, & Moses Rodriguez. (1997). Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. Journal of the Neurological Sciences. 150(2). 103–113. 29 indexed citations
19.
Metzler, A. E., et al.. (1993). Molecular Characterization of South American Bovine Herpesvirus‐1 Isolates with Monoclonal Antibodies and SDS‐PAGE. Journal of Veterinary Medicine Series B. 40(1-10). 125–130. 14 indexed citations
20.
Rodriguez, Moses, et al.. (1991). The immunopathology of multiple sclerosis. 4(2). 186–190. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomas Olsson Breakdown of academic impact, for papers by Reinhard Hohlfeld Breakdown of academic impact, for papers by Richard A. Rudick Breakdown of academic impact, for papers by Ralf Gold Breakdown of academic impact, for papers by Wolfgang Brück Breakdown of academic impact, for papers by Jack P. Antel Breakdown of academic impact, for papers by Amit Bar‐Or Breakdown of academic impact, for papers by Cedric S. Raine Breakdown of academic impact, for papers by W. I. McDonald Breakdown of academic impact, for papers by Hans‐Peter Hartung
Rankless by CCL
2026